BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Clematis Chinensis

53+ PubMed studies analyzed · Evidence Score: 27.6

Research Domains

Clematis Chinensis has been studied across 17 research domains including 🔬 Inflammation, 🦴 Bone & Joint, 🔬 Oncology, 🛡️ Immunity, ✨ Skin & Hair. The primary research focus is 🔬 Inflammation with 36% of studies addressing this area.

Traditional Use (Ayurveda)

Known as weilingxian / 威靈仙 in Ayurveda. Karma (actions): Disperses all wind, Promotes and unblocks the five zang organs, Removes cold stagnation in the abdomen, Eliminates phlegm-water from the Heart and diaphragm, Expels long-accumulated masses and stagnation, Drains old pus and foul water from the bladder, Relieves cold pain in the lumbar region and knees, Treats fractures and injuries, Pushes out old and new accumulations and stagnation, Disperses phlegm and spittle in the chest, Disperses wind evil from the skin and large intestine.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Clematis Chinensis, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

dioscorea
8 shared targets
plantago
7 shared targets
acorus
9 shared targets
angelica
10 shared targets
boswellia
5 shared targets
astragalus
6 shared targets
coptis
3 shared targets
cistanche
2 shared targets
daemonorops
5 shared targets
citrus
5 shared targets
Loading evidence profile...

This evidence profile for Clematis Chinensis is generated deterministically from 53 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.